IART · Integra Lifesciences
The AI's read
The story provides no update on Integra's sales, products, or business results. A share-price change alone does not show those things changed, so this report does not change how we read the company.
Integra LifeSciences shares rose 31.97% in Tuesday's premarket session. The article gives no company news to explain the rise, so it does not change the company's outlook.
The story provides no update on Integra's sales, products, or business results. A share-price change alone does not show those things changed, so this report does not change how we read the company.
SCWorx shares rose 47.8% in Tuesday's premarket session. The article gives no company news to explain the rise, so it does not change the company's outlook.
Rapport Therapeutics shares rose 23.25% in Tuesday's premarket session. The article gives no company news to explain the rise, so it does not change the company's outlook.
MapLight Therapeutics shares rose 17.87% in Tuesday's premarket session. The article gives no company news to explain the rise, so it does not change the company's outlook.
Scilex Holding shares rose 13.54% in Tuesday's premarket session. The article gives no company news to explain the rise, so it does not change the company's outlook.
Icecure Medical shares rose 10.18% in Tuesday's premarket session. The article gives no company news to explain the rise, so it does not change the company's outlook.
Follow Integra Lifesciences (IART) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IART